Literature DB >> 22555904

Movement disorders in autoimmune diseases.

José Fidel Baizabal-Carvallo1, Joseph Jankovic.   

Abstract

Movement disorders have been known to be associated with a variety of autoimmune diseases, including Sydenham's chorea, pediatric autoimmune neuropsychiatric disorders associated with streptococcus, systemic lupus erythematosus, antiphospholipid syndrome, gluten sensitivity, paraneoplastic and autoimmune encephalopathies. Tremors, dystonia, chorea, ballism, myoclonus, parkinsonism, and ataxia may be the initial and even the only presentation of these autoimmune diseases. Although antibodies directed against various cellular components of the central nervous system have been implicated, the pathogenic mechanisms of these autoimmune movement disorders have not yet been fully elucidated. Clinical recognition of these autoimmune movement disorders is critically important as many improve with immunotherapy or dietary modifications, particularly when diagnosed early. We discuss here the clinical features, pathogenic mechanisms, and treatments of movement disorders associated with autoimmune diseases, based on our own experience and on a systematic review of the literature.
Copyright © 2012 Movement Disorder Society.

Entities:  

Mesh:

Year:  2012        PMID: 22555904     DOI: 10.1002/mds.25011

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  33 in total

1.  Diurnal Salivary Cortisol and Regression Status in MECP2 Duplication Syndrome.

Authors:  Sarika U Peters; Breanne J Byiers; Frank J Symons
Journal:  J Child Neurol       Date:  2015-05-21       Impact factor: 1.987

2.  Cerebellar and cortical hypometabolism in progressive stimulus-sensitive limb myoclonus in celiac disease.

Authors:  Stefano Mozzetta; Miryam Carecchio; Gianmarco Gazzola; Diego Cecchin; Annachiara Cagnin
Journal:  Neurol Sci       Date:  2021-04-23       Impact factor: 3.307

3.  Efficacy of high dose methylprednisolone in a patient with cervical dystonia and blepharospasm and Sjögren's syndrome.

Authors:  Vittorio Mantero; Roberto Balgera; Andrea Rigamonti; Francesco Basso; Andrea Salmaggi
Journal:  Neurol Sci       Date:  2014-07-25       Impact factor: 3.307

Review 4.  Movement Disorders in Metabolic Disorders.

Authors:  José Luiz Pedroso; Orlando G Barsottini; Alberto J Espay
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-09       Impact factor: 5.081

Review 5.  Medical and Surgical Treatments for Dystonia.

Authors:  H A Jinnah
Journal:  Neurol Clin       Date:  2020-03-02       Impact factor: 3.806

Review 6.  Acquired ataxias: the clinical spectrum, diagnosis and management.

Authors:  Wolfgang Nachbauer; Andreas Eigentler; Sylvia Boesch
Journal:  J Neurol       Date:  2015-03-26       Impact factor: 4.849

Review 7.  Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  José Fidel Baizabal-Carvallo; Cecilia Bonnet; Joseph Jankovic
Journal:  J Neural Transm (Vienna)       Date:  2013-04-13       Impact factor: 3.575

8.  Gluten ataxia in Japan.

Authors:  Kazunori Nanri; Hiroshi Mitoma; Masafumi Ihara; Nobuyuki Tanaka; Takeshi Taguchi; Masafumi Takeguchi; Tomoko Ishiko; Hidehiro Mizusawa
Journal:  Cerebellum       Date:  2014-10       Impact factor: 3.847

Review 9.  The focal dystonias: current views and challenges for future research.

Authors:  H A Jinnah; Alfredo Berardelli; Cynthia Comella; Giovanni Defazio; Mahlon R Delong; Stewart Factor; Wendy R Galpern; Mark Hallett; Christy L Ludlow; Joel S Perlmutter; Ami R Rosen
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

Review 10.  Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.

Authors:  Nicki Niemann; Joseph Jankovic
Journal:  Drugs       Date:  2018-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.